4.06
0.16 (4.10%)
Previous Close | 3.90 |
Open | 3.95 |
Volume | 855,533 |
Avg. Volume (3M) | 1,304,643 |
Market Cap | 259,594,848 |
Price / Sales | 19.65 |
Price / Book | 1.48 |
52 Weeks Range | |
Earnings Date | 20 Nov 2025 |
Operating Margin (TTM) | -500.53% |
Diluted EPS (TTM) | -0.910 |
Quarterly Revenue Growth (YOY) | 10.30% |
Total Debt/Equity (MRQ) | 4.18% |
Current Ratio (MRQ) | 5.30 |
Operating Cash Flow (TTM) | -37.48 M |
Levered Free Cash Flow (TTM) | -20.36 M |
Return on Assets (TTM) | -17.89% |
Return on Equity (TTM) | -30.11% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Mixed | Bearish |
Medical Devices (Global) | Mixed | Bearish | |
Stock | NANO-X IMAGING LTD | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | -0.5 |
Insider Activity | NA |
Price Volatility | 0.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 2.0 |
Average | 0.50 |
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Growth |
% Held by Insiders | 0.23% |
% Held by Institutions | 24.70% |
52 Weeks Range | ||
Median | 8.00 (97.04%) | |
Total | 1 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
D. Boral Capital | 19 Sep 2025 | 8.00 (97.04%) | Buy | 3.97 |
13 Aug 2025 | 8.00 (97.04%) | Buy | 4.55 |
No data within this time range.
Date | Type | Details |
---|---|---|
18 Sep 2025 | Announcement | Nanox Announces Multi-Segment Healthcare Collaboration with Monarch Medical Management to Expand Access to Advanced Medical Imaging |
12 Aug 2025 | Announcement | Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update |
01 Aug 2025 | Announcement | Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |